SCM
Silverarc Capital Management’s Soleno Therapeutics SLNO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.1M | Buy |
204,591
+38,174
| +23% | +$3.2M | 3.16% | 12 |
|
2025
Q1 | $11.9M | Buy |
+166,417
| New | +$11.9M | 2.43% | 12 |
|
2024
Q3 | – | Sell |
-15,000
| Closed | -$612K | – | 77 |
|
2024
Q2 | $612K | Buy |
+15,000
| New | +$612K | 0.14% | 61 |
|
2024
Q1 | – | Sell |
-73,665
| Closed | -$2.97M | – | 89 |
|
2023
Q4 | $2.97M | Sell |
73,665
-296,335
| -80% | -$11.9M | 0.88% | 41 |
|
2023
Q3 | $10.9M | Buy |
+370,000
| New | +$10.9M | 3.31% | 4 |
|
2021
Q2 | – | Sell |
-125,000
| Closed | -$158K | – | 107 |
|
2021
Q1 | $158K | Sell |
125,000
-197,798
| -61% | -$250K | 0.09% | 83 |
|
2020
Q4 | $623K | Buy |
+322,798
| New | +$623K | 0.36% | 63 |
|